iproniazid has been researched along with phentermine in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (28.57) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Seiler, KU; Wasserman, O | 1 |
Opitz, K; Weischer, ML | 1 |
Maher, TJ; Ulus, IH; Wurtman, RJ | 1 |
1 review(s) available for iproniazid and phentermine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for iproniazid and phentermine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
MAO-inhibitory properties of anorectic drugs.
Topics: Animals; Appetite Depressants; Chlorphentermine; Dose-Response Relationship, Drug; Hypertension, Pulmonary; In Vitro Techniques; Iproniazid; Lung; Methysergide; Mitochondria, Liver; Monoamine Oxidase Inhibitors; Oxazoles; Phenmetrazine; Phentermine; Rats; Serotonin Antagonists | 1973 |
[The excretion of anorectic phenylalkylamines in the urine].
Topics: Animals; Appetite Depressants; Carbamates; Chlorphentermine; Chromatography, Thin Layer; Fenfluramine; Fluorine; Iproniazid; Male; Phenethylamines; Phentermine; Rats | 1966 |
Characterization of phentermine and related compounds as monoamine oxidase (MAO) inhibitors.
Topics: Animals; Antidepressive Agents; Brain; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Ephedrine; Iproniazid; Liver; Lung; Male; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phentermine; Rats; Rats, Sprague-Dawley | 2000 |